Search research articles
Contact Us
Filters
Showing results (251-260 of 269) with videos related to
Page
of 27
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 27, 2020
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis
Robert Spiera, Laura Hummers, Lorinda Chung, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 5, 2015
A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis
Lisa M Rice, Jessica Ziemek, Eric A Stratton, et al.
Journal of Scleroderma and Related Disorders
|
June 28, 2021
Mast Cell Activation in the Systemic Sclerosis Esophagus
Kevin Tom, Bhaven K Mehta, Aileen Hoffmann, et al.
Journal of Racial and Ethnic Health Disparities
|
January 8, 2022
Implementation of Client-Centered Care Coordination for HIV Prevention with Black Men Who Have Sex with Men: Activities, Personnel Costs, and Outcomes-HPTN 073
Darren L Whitfield, LaRon E Nelson, Arnošt Komárek, et al.
JCI Insight
|
December 27, 2016
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity
Shane Lofgren, Monique Hinchcliff, Mary Carns, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 7, 2016
Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics
Jennifer L Sargent, Zhenghui Li, Antonios O Aliprantis, et al.
Arthritis Research & Therapy
|
July 30, 2015
Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
Jaclyn N Taroni, Viktor Martyanov, Chiang-Ching Huang, et al.
The Journal of Investigative Dermatology
|
February 3, 2018
Mycophenolate Mofetil Treatment of Systemic Sclerosis Reduces Myeloid Cell Numbers and Attenuates the Inflammatory Gene Signature in Skin
Monique Hinchcliff, Diana M Toledo, Jaclyn N Taroni, et al.
Arthritis Care & Research
|
September 17, 2021
Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data
Lynette Keyes-Elstein, Ashley Pinckney, Ellen Goldmuntz, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
May 6, 2020
Impact of COVID-19 on Pediatric Gastroenterology Fellow Training in North America
Daniel Mallon, John F Pohl, Uma P Phatak, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 269) with videos related to
Sort By:
Page
of 27
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 27, 2020
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis
Robert Spiera, Laura Hummers, Lorinda Chung, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 5, 2015
A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis
Lisa M Rice, Jessica Ziemek, Eric A Stratton, et al.
Journal of Scleroderma and Related Disorders
|
June 28, 2021
Mast Cell Activation in the Systemic Sclerosis Esophagus
Kevin Tom, Bhaven K Mehta, Aileen Hoffmann, et al.
Journal of Racial and Ethnic Health Disparities
|
January 8, 2022
Implementation of Client-Centered Care Coordination for HIV Prevention with Black Men Who Have Sex with Men: Activities, Personnel Costs, and Outcomes-HPTN 073
Darren L Whitfield, LaRon E Nelson, Arnošt Komárek, et al.
JCI Insight
|
December 27, 2016
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity
Shane Lofgren, Monique Hinchcliff, Mary Carns, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 7, 2016
Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics
Jennifer L Sargent, Zhenghui Li, Antonios O Aliprantis, et al.
Arthritis Research & Therapy
|
July 30, 2015
Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
Jaclyn N Taroni, Viktor Martyanov, Chiang-Ching Huang, et al.
The Journal of Investigative Dermatology
|
February 3, 2018
Mycophenolate Mofetil Treatment of Systemic Sclerosis Reduces Myeloid Cell Numbers and Attenuates the Inflammatory Gene Signature in Skin
Monique Hinchcliff, Diana M Toledo, Jaclyn N Taroni, et al.
Arthritis Care & Research
|
September 17, 2021
Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data
Lynette Keyes-Elstein, Ashley Pinckney, Ellen Goldmuntz, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
May 6, 2020
Impact of COVID-19 on Pediatric Gastroenterology Fellow Training in North America
Daniel Mallon, John F Pohl, Uma P Phatak, et al.
Page
of 27